Cecelia Haines Boardman, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

University Of Pittsburgh School Of Medicine - Pittsburgh PA
Rank: Instructor
Years: 1992-1997

Mayo Medical School - Rochester MN
Rank: visiting scientist
Years: 2000-2002

Virginia Commonwealth University School Of Medicine (Previously MCV) - Richmond VA
Rank: Assistant Professor
Years: 2000-present

None Reported

Peritoneal carcinomatosis from cervical cancer detected by F-18 FDG positron emission tomography.
Clin Nuc Med
Volume: 30(1)
Date: 01 2005

Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Ca Epi and Biomarkers Prev
Volume: 14(2)
Date: 02 2005

Biologic therapeutics and molecular profiling to optimize wound healing.
Gynecologic Oncology
epub ahead of print
Date: 09 2008

Soluble Epidermal Growth Factor Receptor: A Biomarker of Epithelial Ovarian Cancer.
Cancer Treatment Res.
Volume: 149
Date: 01 2009

A Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group.
Jounal of Clinical Oncology
Volume: 27
Date: 06 2009

Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVb, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study.
Journal of Clinical Oncology
Volume: 27
Date: 10 2009

Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study
Gynecologic Oncology
Volume: 119(3)
Date: 12 2010

A pilot phase II trial of magnesium supplements to reduce menopausal hot flashes in breast cancer patients
Support Care Cancer
Volume: 19(6)
Date: 06 2011

Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study
Gynecologic Oncology
Volume: 122(3)
Date: 09 2011